Type 2 diabetics followed up by family ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Type 2 diabetics followed up by family physicians: Treatment sequences and changes over time in weight and glycated hemoglobin.
Auteur(s) :
Boullenger, Lena [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Quindroit, Paul [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Legrand, Bertrand [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Balcaen, Thibault [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Calafiore, Matthieu [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Rochoy, Michaël [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Beuscart, Jean-Baptiste [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Chazard, Emmanuel [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Quindroit, Paul [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Legrand, Bertrand [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Balcaen, Thibault [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Calafiore, Matthieu [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Rochoy, Michaël [Auteur]
Evaluation des technologies de santé et des pratiques médicales - ULR 2694 [METRICS]
Beuscart, Jean-Baptiste [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Chazard, Emmanuel [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Titre de la revue :
Primary Care Diabetes
Nom court de la revue :
Prim Care Diabetes
Numéro :
16
Pagination :
P670-676
Date de publication :
2022-07-24
ISSN :
1878-0210
Mot(s)-clé(s) en anglais :
Type 2 diabetes mellitus
Data reuse
Glycated hemoglobin
General practice
Electronic health records
Data reuse
Glycated hemoglobin
General practice
Electronic health records
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Introduction
The treatment of type 2 diabetes mellitus (T2DM) is based on preventive hygiene and dietary measures (HDM), oral antidiabetic drugs (OADs), and insulin. The objective of the present study was to reuse general ...
Lire la suite >Introduction The treatment of type 2 diabetes mellitus (T2DM) is based on preventive hygiene and dietary measures (HDM), oral antidiabetic drugs (OADs), and insulin. The objective of the present study was to reuse general practice data from electronic health records and describe changes over time among patients with T2DM in primary care. Methods We analyzed data on patients with T2DM collected by three family physicians in Tourcoing (France) from 2006 to 2018. Results 403 patients, 1030 treatment sequences, 39,042 appointments, 2440 glycated hemoglobin (HbA1c) measurements, and 9722 wt measurements were included. On inclusion, the mean age was 57.0, the mean weight was 84.4 kg, the mean body mass index was 30.3 kg/m2, and the median HbA1c level was 6.8 % (51 mmol/mol). The patients were following appropriate HDM (40.7 %) and/or were being treated with OADs (54.1 %) or insulin (5.2 %). The median length of follow-up was 3.51 years. Overall, bodyweight was stable for two years during HDM and then increased. The HbA1c level decreased and then increased during HDM, was stable on OADs, and then decreased on insulin.Lire moins >
Lire la suite >Introduction The treatment of type 2 diabetes mellitus (T2DM) is based on preventive hygiene and dietary measures (HDM), oral antidiabetic drugs (OADs), and insulin. The objective of the present study was to reuse general practice data from electronic health records and describe changes over time among patients with T2DM in primary care. Methods We analyzed data on patients with T2DM collected by three family physicians in Tourcoing (France) from 2006 to 2018. Results 403 patients, 1030 treatment sequences, 39,042 appointments, 2440 glycated hemoglobin (HbA1c) measurements, and 9722 wt measurements were included. On inclusion, the mean age was 57.0, the mean weight was 84.4 kg, the mean body mass index was 30.3 kg/m2, and the median HbA1c level was 6.8 % (51 mmol/mol). The patients were following appropriate HDM (40.7 %) and/or were being treated with OADs (54.1 %) or insulin (5.2 %). The median length of follow-up was 3.51 years. Overall, bodyweight was stable for two years during HDM and then increased. The HbA1c level decreased and then increased during HDM, was stable on OADs, and then decreased on insulin.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
CHU Lille
CHU Lille
Date de dépôt :
2023-11-15T03:40:21Z
2024-04-19T07:53:29Z
2024-04-19T07:53:29Z